Regenerative medicine aims to restore damaged tissue using cells, growth factors and biomaterials, including the patient’s own substances. Ophthalmology is one of the most actively researched areas: some methods are already used in clinical practice, others are still being studied in clinical trials.
The retina
The retina is the most important part of the visual organ: it converts light signals into nerve impulses, which travel along the optic nerve to the brain and create visual sensations.
Histologically, the retina consists of a chain of three neurons — outer (photoreceptor), middle (associative) and inner (ganglion) — forming 10 layers. Like brain tissue, retinal nerve tissue regenerates very poorly, which is why diseases of the retina and optic nerve are so difficult to treat.
Where regenerative methods are already used
- Corneal repair. For limbal stem cell deficiency (for example after a chemical burn of the eye), a product made from the patient’s own laboratory-grown stem cells is approved in Europe.
- Autologous serum and platelet-rich plasma (PRP) eye drops — for severe dry eye and poorly healing corneal defects.
- Amniotic membrane — to heal damage to the surface of the eye.
What is being studied in clinical trials
The use of stem cells and growth factors in diseases of the retina and optic nerve is still experimental. Research is under way in:
- age-related macular degeneration (including transplantation of retinal pigment epithelium cells);
- retinitis pigmentosa and other inherited retinal dystrophies (an approved gene therapy already exists for one form);
- diabetic retinopathy;
- optic nerve atrophy and optic neuritis, including in multiple sclerosis;
- consequences of injuries to the eyeball and optic nerve.
The first results are encouraging, but there is not yet enough evidence of effectiveness for widespread use. The standard of care for many of these diseases remains proven methods: anti-VEGF injections for wet macular degeneration and diabetic macular oedema, laser treatment and surgery.
Important: in some countries clinics offer “stem cell treatment” without an evidence base, and such procedures have already caused serious complications, including blindness. Regenerative methods should therefore only be considered in certified university centres or within official clinical trials. We can arrange a consultation with leading ophthalmologists in Germany to assess whether modern standard or investigational treatments are suitable for you.